scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023063278 |
P356 | DOI | 10.1007/S00296-012-2402-8 |
P8608 | Fatcat ID | release_4xcuhacqqbbsrhsvbyp76udkjy |
P698 | PubMed publication ID | 22527136 |
P2093 | author name string | Maria Isabel T D Correia | |
Rosa Weiss Telles | |||
Cristina Costa Duarte Lanna | |||
Mariane Curado Borges | |||
Fabiana de Miranda Moura dos Santos | |||
P2860 | cites work | Clinical practice. Primary ovarian insufficiency | Q24653014 |
Prevalence of overweight and obesity in the United States, 1999-2004 | Q28305811 | ||
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
International physical activity questionnaire: 12-country reliability and validity | Q29615137 | ||
The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. | Q31114844 | ||
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort | Q33915430 | ||
Methotrexate in systemic lupus erythematosus | Q36063859 | ||
Systemic lupus erythematosus and exercise | Q36729461 | ||
Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee | Q36823478 | ||
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity | Q37435268 | ||
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 | ||
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. | Q41109148 | ||
Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual | Q41912319 | ||
Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy | Q41919785 | ||
Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge. | Q42771406 | ||
Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. | Q43275139 | ||
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. | Q43417859 | ||
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group | Q43589680 | ||
The 10-year incidence of overweight and major weight gain in US adults | Q43844390 | ||
Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity | Q44237948 | ||
Methotrexate use in patients with systemic lupus erythematosus | Q45078984 | ||
Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus | Q46144242 | ||
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial | Q46227344 | ||
Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain | Q46404846 | ||
Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus | Q48666386 | ||
Biochemical characterization of ADP-ribose polymer metabolism in SLE. | Q51031046 | ||
Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients. | Q51464078 | ||
Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 | ||
Socioeconomic status and weight control practices among 20- to 45-year-old women | Q71158521 | ||
Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise | Q73350605 | ||
Diagnosis and classification of diabetes mellitus | Q75205667 | ||
Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
Body mass index and the risk of development of end-stage renal disease in a screened cohort | Q79933214 | ||
[V Brazilian Guidelines in Arterial Hypertension. ] | Q81376428 | ||
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus | Q81420605 | ||
Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus | Q81602795 | ||
P433 | issue | 3 | |
P304 | page(s) | 681-688 | |
P577 | publication date | 2012-04-22 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | Excess weight and associated risk factors in patients with systemic lupus erythematosus. | |
P478 | volume | 33 |
Q93054220 | A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases |
Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q47216525 | Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus? |
Q98465680 | Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review |
Q35542454 | Serum Immunoglobulin M Concentration Varies with Triglyceride Levels in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study |
Search more.